Seeking Alpha

OXiGENE (OXGN) and the FDA reach a deal on a special protocol assessment for the Phase 3 trial...

OXiGENE (OXGN) and the FDA reach a deal on a special protocol assessment for the Phase 3 trial of its thyriod cancer drug zybrestat. Shares +14.8% AH.
Comments (2)
  • smokeyRose
    , contributor
    Comments (78) | Send Message
     
    I am with this stock!!!
    20 Sep 2012, 01:35 AM Reply Like
  • smokeyRose
    , contributor
    Comments (78) | Send Message
     
    I Bought this stock long ago for $2.00. the stock went up to $20.00!
    I Believe in this stock, at 66 cents ya can't go wrong!
    20 Sep 2012, 01:37 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|